CBD Lion Merger ~~~ <br /> <br /> On July 31, 2019, our Board adopted resolutions approving and authorizing the Merger and on May 24, 2019, our Board signed a unanimous written consent to the Amendment containing the Name Change. Effective as of October 1, 2019, a majority of the stockholders of the Company took action by written consent and approved the Merger and an amendment to the Company’s Articles of Incorporation with respect to the Name Change. <br /> <br /> <br /> <br /> As of the Record Date, the Company has authorized capital stock of 110,000,000 shares, of which 100,000,000 are shares of Common Stock and 10,000,000 are shares of preferred stock. As of November 1, 2019, 2,726,669 shares of our common stock were issued and outstanding, held by 243 holders of record. As of November 1, 2019, 66,150 shares of our Series A Preferred Stock and 90,000 shares of our Series B Preferred Stock were issued and outstanding. Our common stock is traded on the OTC Markets under the ticker symbol ASQP.